Event

Samir Arora

MD
Aventiv Research;Aventiv Research Inc.

Andrea Maes

PhD
Pearl Therapeutics Inc.

David J. Collier

MBBS, PhD
Barts and the London School of Medicine and Dentistry, Queen Mary University of London

Yasuhiro Gon

MD, PhD
Itabashi Hospital, Nihon University School of Medicine, Itabashi;Nihon University;Nihon University School of Medicine

Rongchang Chen

MD, FCCP
First Affiliated Hospital Of Guangzhou Medical University;National Clinical Research Centre for Respiratory Diseases, First Affiliated Hospital of Guangzhou M;State Key Lab of Respiratory Disease, Nat

Nanshan Zhong

MD, FCCP
Guangzhou Medical University;National Clinical Research Centre for Respiratory Diseases, First Affiliated Hospital of Guangzhou M;State Key Lab of Respiratory Disease, National Clinical Research Cente

Colin Reisner

MD
Pearl Therapeutics Inc;Pearl Therapeutics Inc.;Pearl Therapeutics, a member of the AstraZeneca Group

Ubaldo J. Martin

MD
AstraZeneca

Koichi Nishi

MD, PhD
Ishikawa Prefectural Central Hospital

Shahid Siddiqui

MD
AstraZeneca

Brian Lipworth

MD
Ninewells Hospital, University of Dundee

Glycopyrrolate/Formoterol Fumarate Fixed-Dose Combination Delivered by Metered Dose Inhaler Improves Lung Function and Symptoms in Patients with COPD: Results from the PINNACLE-4 Study in Asia, Europe, and the USA